Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
0.6900
Dollar change
0.0000
Percentage change
0.00
%
Index- P/E- EPS (ttm)- Insider Own57.02% Shs Outstand27.60M Perf Week1.47%
Market Cap19.23M Forward P/E- EPS next Y-1.05 Insider Trans0.00% Shs Float11.98M Perf Month-10.39%
Income- PEG- EPS next Q- Inst Own10.93% Short Float0.09% Perf Quarter-39.47%
Sales- P/S- EPS this Y-9.35% Inst Trans-0.69% Short Ratio0.30 Perf Half Y-36.11%
Book/sh-0.60 P/B- EPS next Y39.37% ROA- Short Interest0.01M Perf Year-4.18%
Cash/sh0.55 P/C1.25 EPS next 5Y- ROE- 52W Range0.60 - 2.52 Perf YTD-42.50%
Dividend Est.- P/FCF- EPS past 5Y-32.60% ROI- 52W High-72.62% Beta-0.81
Dividend TTM- Quick Ratio1.37 Sales past 5Y29.11% Gross Margin- 52W Low15.00% ATR (14)0.08
Dividend Ex-Date- Current Ratio1.45 EPS Y/Y TTM-232.59% Oper. Margin-60.98% RSI (14)39.46 Volatility14.48% 11.30%
Employees517 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price1.50
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-13.12% Payout- Rel Volume0.00 Prev Close0.69
Sales Surprise- EPS Surprise- Sales Q/Q-80.94% EarningsSep 07 AMC Avg Volume37.57K Price0.69
SMA20-0.05% SMA50-23.69% SMA200-36.09% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Aug-05-21Resumed Credit Suisse Outperform $14
Apr-24-20Downgrade Evercore ISI Outperform → In-line $21
Dec-03-19Initiated Robert W. Baird Outperform
Dec-02-19Initiated Evercore ISI Outperform
Dec-02-19Initiated BTIG Research Buy
Mar-19-24 06:30AM
Feb-29-24 05:00PM
Feb-28-24 06:30AM
06:30AM
Jan-25-24 06:30AM
06:30AM Loading…
Jan-24-24 06:30AM
Jan-23-24 06:30AM
Jan-18-24 06:30AM
Dec-19-23 06:30AM
Dec-13-23 06:30AM
Nov-28-23 06:30AM
Nov-14-23 08:30AM
Oct-10-23 06:30AM
Sep-11-23 08:30AM
Sep-07-23 05:00PM
08:00AM Loading…
Sep-01-23 08:00AM
Aug-31-23 04:30PM
Aug-07-23 06:30AM
Jul-14-23 06:30AM
Jul-12-23 07:30AM
Jul-02-23 05:00AM
Jun-30-23 04:30PM
Jun-27-23 07:30AM
Jun-14-23 04:30PM
May-16-23 06:25PM
May-05-23 06:30AM
Apr-28-23 06:30AM
Apr-26-23 04:14PM
08:30AM
Apr-14-23 08:00AM
06:30AM Loading…
Apr-12-23 06:30AM
Apr-11-23 06:30AM
Mar-09-23 06:30AM
Mar-08-23 06:30AM
Feb-22-23 09:40AM
Feb-21-23 06:30AM
Feb-07-23 08:00AM
06:30AM
Jan-10-23 08:00AM
Jan-09-23 08:30AM
08:00AM
Dec-28-22 06:30AM
Dec-24-22 08:24AM
Dec-22-22 04:00PM
Dec-16-22 04:30PM
Dec-01-22 06:30AM
Nov-23-22 12:59PM
Nov-21-22 06:30AM
Nov-10-22 06:30AM
Nov-03-22 06:00AM
Oct-06-22 06:00AM
Oct-03-22 08:00AM
Sep-01-22 06:30AM
Jul-15-22 08:15AM
Jun-27-22 04:01PM
04:01PM
Jun-13-22 06:30AM
Jun-02-22 05:25PM
May-25-22 05:35PM
06:30AM
May-23-22 06:30AM
May-19-22 06:30AM
May-06-22 08:01AM
Apr-28-22 06:30AM
Mar-30-22 01:00PM
07:30AM
Mar-24-22 06:30AM
Mar-23-22 06:30AM
Mar-17-22 06:30AM
Feb-22-22 06:30AM
Feb-08-22 06:30AM
Feb-01-22 08:24AM
05:30AM
05:30AM
05:30AM
Jan-20-22 06:30AM
Jan-04-22 08:00AM
Dec-23-21 08:00AM
Dec-20-21 08:30AM
Dec-18-21 07:17AM
Nov-24-21 08:55AM
07:35AM
Nov-18-21 06:30AM
Nov-04-21 06:30AM
Oct-28-21 06:30AM
Oct-19-21 07:20AM
Oct-06-21 08:00AM
Sep-30-21 07:05AM
Sep-29-21 05:05PM
Sep-07-21 04:00PM
07:55AM
06:35AM
Sep-01-21 06:30AM
Jul-27-21 06:30AM
Jun-25-21 06:30AM
Jun-22-21 06:30AM
Jun-19-21 04:34AM
Jun-16-21 08:00AM
06:30AM
Jun-15-21 08:14AM
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.